This page shows the latest respiratory syncytial virus news and features for those working in and with pharma, biotech and healthcare.
Pfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo, that can help to protect infants through the active immunisation of pregnant women, has been backed by the US Centers for Disease Control ... RSV is a common respiratory virus that
Designed to increase the efficiency of manufacturing processes and reduce environmental impact, the new unit will handle freeze-dried vaccines, including the company’s respiratory syncytial virus (RSV) vaccine, Arexvy.
both HA and neuraminidase antigens to target multiple proteins involved in the influenza virus life cycle. ... With [the] positive phase 3 flu results, along with previous results in COVID-19 and respiratory syncytial virus, we are now three for three on
The investment follows the launch of the company’s new respiratory syncytial virus (RSV) vaccine, Arexvy.
Pfizer's respiratory syncytial virus (RSV) vaccine has been approved by the European Commission (EC) to protect both infants and older adults against RSV-caused lower respiratory tract disease (LRTD). ... RSV is a common contagious virus characterised by
Pfizer’s respiratory syncytial virus (RSV) vaccine has been approved by the US Food and Drug Administration (FDA) to protect infants through the active immunisation of pregnant individuals. ... RSV is a common contagious virus characterised by several
More from news
Approximately 25 fully matching, plus 61 partially matching documents found.
Up to that point, the drug was being developed to treat respiratory viral infections in patients with COPD who are at risk of experiencing exacerbations, which can be deadly and typically ... challenge study, in this case respiratory syncytial virus (RSV)
In the absence of a knockout antiviral, researchers are trying to mitigate harmful effects of the virus. ... Scientists have since industrialised the concept, leading to the development of antibodies against Ebola and respiratory syncytial virus.
has encouraged people to knit hats and blankets for babies to alert people to respiratory syncytial virus.
In order to focus its respiratory resources on products such as Symbicort and benralizumab, AstraZeneca has agreed that its product Tudorza (marketed for COPD) and Duaklir (in phase III for COPD) ... Headline. $m. AstraZeneca/ MedImmune. Sanofi Pasteur.
Alios has an oral anti-viral in phase 2 for treatment of infant respiratory syncytial virus (RSV) which complements J&J's early stage programmes in RSV.
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
During the last 12 months Mucosis has completed a clinical proof of concept study in human influenza for Mimopath and advanced respiratory syncytial virus (RSV) candidate SynGEM into pre-clinical studies.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...